SUN PHARMA ADVANCED RESEARCH COMPANY
Back to Balance Sheet
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|---|
| Contingent Liabilities | ₹85 Cr | ₹85 Cr | ₹84 Cr | ₹84 Cr |
What is the latest Contingent Liabilities ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹85 Cr |
| Mar2025 | ₹85 Cr |
| Mar2024 | ₹84 Cr |
| Mar2023 | ₹84 Cr |
How is Contingent Liabilities of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹85 Cr | -0.06 | |
| Mar2025 | ₹85 Cr | 1.47 | |
| Mar2024 | ₹84 Cr | 0.00 | |
| Mar2023 | ₹84 Cr | - | |
Compare Contingent Liabilities of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹6,363.4 Cr | -4.9% | -3.9% | 39.5% | Stock Analytics | |
| PRIME FOCUS | ₹24,188.7 Cr | -0.6% | 12.9% | 79.8% | Stock Analytics | |
| SAGILITY | ₹21,136.2 Cr | -1.7% | 5.8% | 6.1% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹15,446.4 Cr | -1.8% | -4.7% | -40.8% | Stock Analytics | |
| INDEGENE | ₹13,929.1 Cr | -3.6% | 1.5% | 4.3% | Stock Analytics | |
| INTERNATIONAL GEMOLOGICAL INSTITUTE | ₹13,578.5 Cr | -1.1% | -9% | -11.2% | Stock Analytics | |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMA ADVANCED RESEARCH COMPANY | -4.9% |
-3.9% |
39.5% |
| SENSEX | -2.3% |
-4.1% |
-7.4% |
You may also like the below Video Courses